Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Engels

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 16, 2024
Evaluation of chemotherapy-induced nausea and vomiting in pediatric patients with high-grade glioma treated with lomustine-a case seriesKim P J Schellekens, Sarah Babette Hageman, Els C Haverkate, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical dataE Ruckhäberle, T Karn, K Engels, et al.
Histology and Histopathology|September 18, 2004
Effects of the tyrosine kinase inhibitor imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemiaJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Der Pathologe|June 5, 2004
[Regression of the Philadelphia chromosome (bcr/abl)-positive myelo- and megakaryopoiesis after Imatinib (STI571) therapy in chronic myelogenous leukemia (CML)]J Thiele, H M Kvasnicka, E Varus, et al.
Blood Advances|November 7, 2025
The Right Glucarpidose?Marise R Heerma van Voss, Maaike A Sikma, Frederike K Engels, et al.
Pediatric Blood & Cancer|February 17, 2017
Drug-drug interactions in pediatric oncology patientsT E Balk, I H van der Sijs, T van Gelder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2006
Epstein-barr virus-associated posttransplant lymphoproliferative disorder of donor origin after simultaneous pancreas-kidney transplantation limited to pancreas allograft: A case reportB Rehbinder, Ch Wullstein, W O Bechstein, et al.
The Oncologist|April 5, 2007
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxelFrederike K Engels, Floris A de Jong, Alex Sparreboom, et al.
Histopathology|April 22, 2005
Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 16, 2024
Evaluation of chemotherapy-induced nausea and vomiting in pediatric patients with high-grade glioma treated with lomustine-a case seriesKim P J Schellekens, Sarah Babette Hageman, Els C Haverkate, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical dataE Ruckhäberle, T Karn, K Engels, et al.
Histology and Histopathology|September 18, 2004
Effects of the tyrosine kinase inhibitor imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemiaJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Der Pathologe|June 5, 2004
[Regression of the Philadelphia chromosome (bcr/abl)-positive myelo- and megakaryopoiesis after Imatinib (STI571) therapy in chronic myelogenous leukemia (CML)]J Thiele, H M Kvasnicka, E Varus, et al.
Blood Advances|November 7, 2025
The Right Glucarpidose?Marise R Heerma van Voss, Maaike A Sikma, Frederike K Engels, et al.
Pediatric Blood & Cancer|February 17, 2017
Drug-drug interactions in pediatric oncology patientsT E Balk, I H van der Sijs, T van Gelder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2006
Epstein-barr virus-associated posttransplant lymphoproliferative disorder of donor origin after simultaneous pancreas-kidney transplantation limited to pancreas allograft: A case reportB Rehbinder, Ch Wullstein, W O Bechstein, et al.
The Oncologist|April 5, 2007
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxelFrederike K Engels, Floris A de Jong, Alex Sparreboom, et al.
Histopathology|April 22, 2005
Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Pageof 10